Stocks and Investing Stocks and Investing
Fri, January 20, 2023
Thu, January 19, 2023

Christopher Raymond Maintained (AMGN) at Buy with Decreased Target to $293 on, Jan 19th, 2023


Published on 2024-10-28 01:00:04 - WOPRAI, Christopher Raymond
  Print publication without navigation


Christopher Raymond of Piper Sandler, Maintained "Amgen Inc." (AMGN) at Buy with Decreased Target from $299 to $293 on, Jan 19th, 2023.

Christopher has made no other calls on AMGN in the last 4 months.



There are 7 other peers that have a rating on AMGN. Out of the 7 peers that are also analyzing AMGN, 3 agree with Christopher's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Mohit Bansal of "Wells Fargo" Maintained at Hold with Increased Target to $285 on, Tuesday, January 3rd, 2023
  • David Risinger of "SVB Leerink" Maintained at Hold with Increased Target to $282 on, Thursday, December 22nd, 2022
  • Gregory Renza of "RBC Capital" Maintained at Hold with Increased Target to $240 on, Friday, November 4th, 2022


These are the ratings of the 4 analyists that currently disagree with Christopher


  • Carter Gould of "Barclays" Maintained at Sell with Increased Target to $240 on, Wednesday, January 18th, 2023
  • Jay Olson of "Oppenheimer" Maintained at Buy with Increased Target to $310 on, Tuesday, December 6th, 2022
  • Trung Huynh of "Credit Suisse" Initiated at Sell and Held Target at $240 on, Friday, November 18th, 2022
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $282 on, Friday, November 4th, 2022
Contributing Sources